Literature DB >> 19449031

Regional genomic instability predisposes to complex dystrophin gene rearrangements.

Junko Oshima1, Daniel B Magner, Jennifer A Lee, Amy M Breman, Eric S Schmitt, Lisa D White, Carol A Crowe, Michelle Merrill, Parul Jayakar, Aparna Rajadhyaksha, Christine M Eng, Daniela del Gaudio.   

Abstract

Mutations in the dystrophin gene (DMD) cause Duchenne and Becker muscular dystrophies and the majority of cases are due to DMD gene rearrangements. Despite the high incidence of these aberrations, little is known about their causative molecular mechanism(s). We examined 792 DMD/BMD clinical samples by oligonucleotide array-CGH and report on the junction sequence analysis of 15 unique deletion cases and three complex intragenic rearrangements to elucidate potential underlying mechanism(s). Furthermore, we present three cases with intergenic rearrangements involving DMD and neighboring loci. The cases with intragenic rearrangements include an inversion with flanking deleted sequences; a duplicated segment inserted in direct orientation into a deleted region; and a splicing mutation adjacent to a deletion. Bioinformatic analysis demonstrated that 7 of 12 breakpoints combined among 3 complex cases aligned with repetitive sequences, as compared to 4 of 30 breakpoints for the 15 deletion cases. Moreover, the inversion/deletion case may involve a stem-loop structure that has contributed to the initiation of this rearrangement. For the duplication/deletion and splicing mutation/deletion cases, the presence of the first mutation, either a duplication or point mutation, may have elicited the deletion events in an attempt to correct preexisting mutations. While NHEJ is one potential mechanism for these complex rearrangements, the highly complex junction sequence of the inversion/deletion case suggests the involvement of a replication-based mechanism. Our results support the notion that regional genomic instability, aided by the presence of repetitive elements, a stem-loop structure, and possibly preexisting mutations, may elicit complex rearrangements of the DMD gene.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19449031     DOI: 10.1007/s00439-009-0679-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  43 in total

1.  Measurement of locus copy number by hybridisation with amplifiable probes.

Authors:  J A Armour; C Sismani; P C Patsalis; G Cross
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome.

Authors:  K S Chen; P Manian; T Koeuth; L Potocki; Q Zhao; A C Chinault; C C Lee; J R Lupski
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

3.  Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females.

Authors:  Ken Inoue; Hitoshi Osaka; Virginia C Thurston; Joe T R Clarke; Akira Yoneyama; Lisa Rosenbarker; Thomas D Bird; M E Hodes; Lisa G Shaffer; James R Lupski
Journal:  Am J Hum Genet       Date:  2002-09-20       Impact factor: 11.025

Review 4.  Genomic rearrangements and sporadic disease.

Authors:  James R Lupski
Journal:  Nat Genet       Date:  2007-07       Impact factor: 38.330

Review 5.  Dystrophin, its interactions with other proteins, and implications for muscular dystrophy.

Authors:  James M Ervasti
Journal:  Biochim Biophys Acta       Date:  2006-06-07

Review 6.  Dystrophies and heart disease.

Authors:  G F Cox; L M Kunkel
Journal:  Curr Opin Cardiol       Date:  1997-05       Impact factor: 2.161

7.  Back mutation can produce phenotype reversion in Bloom syndrome somatic cells.

Authors:  N A Ellis; S Ciocci; J German
Journal:  Hum Genet       Date:  2001-02       Impact factor: 4.132

8.  Molecular diagnosis of Duchenne/Becker muscular dystrophy: enhanced detection of dystrophin gene rearrangements by oligonucleotide array-comparative genomic hybridization.

Authors:  Daniela del Gaudio; Yaping Yang; Barbara A Boggs; Eric S Schmitt; Jennifer A Lee; Trilochan Sahoo; Hoang T Pham; Joanna Wiszniewska; A Craig Chinault; Arthur L Beaudet; Christine M Eng
Journal:  Hum Mutat       Date:  2008-09       Impact factor: 4.878

9.  Analysis of 22 deletion breakpoints in dystrophin intron 49.

Authors:  Carlo Nobile; Luisa Toffolatti; Francesca Rizzi; Barbara Simionati; Vincenzo Nigro; Barbara Cardazzo; Tomaso Patarnello; Giorgio Valle; Gian Antonio Danieli
Journal:  Hum Genet       Date:  2002-04-09       Impact factor: 4.132

10.  Mechanisms for human genomic rearrangements.

Authors:  Wenli Gu; Feng Zhang; James R Lupski
Journal:  Pathogenetics       Date:  2008-11-03
View more
  25 in total

1.  WRN mutations in Werner syndrome patients: genomic rearrangements, unusual intronic mutations and ethnic-specific alterations.

Authors:  Katrin Friedrich; Lin Lee; Dru F Leistritz; Gudrun Nürnberg; Bidisha Saha; Fuki M Hisama; Daniel K Eyman; Davor Lessel; Peter Nürnberg; Chumei Li; María J Garcia-F-Villalta; Carolien M Kets; Joerg Schmidtke; Vítor Tedim Cruz; Peter C Van den Akker; Joseph Boak; Dincy Peter; Goli Compoginis; Kivanc Cefle; Sukru Ozturk; Norberto López; Theda Wessel; Martin Poot; P F Ippel; Birgit Groff-Kellermann; Holger Hoehn; George M Martin; Christian Kubisch; Junko Oshima
Journal:  Hum Genet       Date:  2010-05-05       Impact factor: 4.132

2.  Becker muscular dystrophy due to an inversion of exons 23 and 24 of the DMD gene.

Authors:  Kevin M Flanigan; Diane Dunn; C Aaron Larsen; Livija Medne; Carsten B Bönnemann; Robert B Weiss
Journal:  Muscle Nerve       Date:  2011-11       Impact factor: 3.217

Review 3.  On the sequence-directed nature of human gene mutation: the role of genomic architecture and the local DNA sequence environment in mediating gene mutations underlying human inherited disease.

Authors:  David N Cooper; Albino Bacolla; Claude Férec; Karen M Vasquez; Hildegard Kehrer-Sawatzki; Jian-Min Chen
Journal:  Hum Mutat       Date:  2011-09-02       Impact factor: 4.878

Review 4.  The function of dog models in developing gene therapy strategies for human health.

Authors:  Keri L Nowend; Alison N Starr-Moss; Keith E Murphy
Journal:  Mamm Genome       Date:  2011-07-06       Impact factor: 2.957

5.  A novel noncontiguous duplication in the DMD gene escapes the 'reading-frame rule'.

Authors:  Luz Berenice López-Hernández; Benjamín Gómez-Díaz; Eliganty Bahena-Martínez; Teresa Neri-Gómez; Alejandra Camacho-Molina; Luis A Ruano-Calderón; Silvia García; Ramón M Coral-Vázquez
Journal:  J Genet       Date:  2014-04       Impact factor: 1.166

6.  Decoding NF1 Intragenic Copy-Number Variations.

Authors:  Meng-Chang Hsiao; Arkadiusz Piotrowski; Tom Callens; Chuanhua Fu; Katharina Wimmer; Kathleen B M Claes; Ludwine Messiaen
Journal:  Am J Hum Genet       Date:  2015-07-16       Impact factor: 11.025

7.  Precise mapping of 17 deletion breakpoints within the central hotspot deletion region (introns 50 and 51) of the DMD gene.

Authors:  Gabriella Esposito; Maria Roberta Tremolaterra; Evelina Marsocci; Igor Cm Tandurella; Tiziana Fioretti; Maria Savarese; Antonella Carsana
Journal:  J Hum Genet       Date:  2017-09-07       Impact factor: 3.172

Review 8.  Normal and altered pre-mRNA processing in the DMD gene.

Authors:  Sylvie Tuffery-Giraud; Julie Miro; Michel Koenig; Mireille Claustres
Journal:  Hum Genet       Date:  2017-06-09       Impact factor: 4.132

9.  De novo mutation in DMD gene in a patient with combined hemophilia A and Duchenne muscular dystrophy.

Authors:  Lana Strmecki; Petra Hudler; Majda Benedik-Dolničar; Radovan Komel
Journal:  Int J Hematol       Date:  2013-12-08       Impact factor: 2.490

10.  A novel splicing silencer generated by DMD exon 45 deletion junction could explain upstream exon 44 skipping that modifies dystrophinopathy.

Authors:  Ery Kus Dwianingsih; Rusdy Ghazali Malueka; Atsushi Nishida; Kyoko Itoh; Tomoko Lee; Mariko Yagi; Kazumoto Iijima; Yasuhiro Takeshima; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2014-05-29       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.